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Abstract— Stevia rebaudiana is a plant widely used as 
sweetener and food supplement. There are some reports 
of the euglycemic effect of S. rebaudiana extracts, which 
has been attributed mainly to stevioside for the results 
obtained by other authors. However, studies with extracts 
lack the precise quantification of glycosides and it is 
known that several agricultural and environmental 
factors affect the steviol glycosides content. The aim of 
this study was to evaluate the euglycemic effect of oral 
administration of extracts of S. rebaudiana varieties 
cultivated in Mexico in normoglycemic and induced-
diabetic Wistar rats and quantify their glycosides content. 
Aqueous leaves extracts of Criolla and Morita II varieties 
of S. rebaudiana were used to quantify glycosides by a 
validated HPLC method or lyophilized for in vivo 
experiments. Hypoglycaemic effect was evaluated in 
normoglycemic fasting rats, subjected to intragastric 
administration of Criolla or Morita II (100 or 200 mg/kg) 
and glucose measured at time 0, 1, 3, 5 and 7 hours. The 
antihyperglycemic effect was first evaluated with 
Streptozotocin / Nicotinamide-induced diabetic rats 
following the methodology previously described, and 
further evaluated with glucose load in normoglycemic 
rats. Control groups were distilled water and 
glibenclamide (5 mg/kg). Stevioside content was 2.08 ± 
0.11 and 5.22 ± 0.23 (g/100 g of dry leaves) in the Morita 
II and Criolla variety, respectively. Acute administration 
of both varieties of S. rebaudiana had no euglycemic 
effect in normoglycemic or induced-diabetic rats (p> 
0.05) at any of the doses tested. 
Keywords— Antihyperglycemic, Hypoglycemic, glucose, 
Stevia rebaudiana Bertoni, Steviol glycosides. 
 
I. INTRODUCTION 
Stevia rebaudiana Bertoni is a plant native of Central and 
South America whose leaves contains steviol glycosides 
with high sweetening capacity. [1] The steviol glycosides 
are compounds derived from steviol, which is 
glycosylated at C-19 and C-13 replacing the carboxyl 
hydrogen with glucose, xylose or rhamnose. [2] 
In 2010, the Joint FAO/WHO Expert Committee for Food 
Additives (JECFA) identified nine steviol glycosides: 
Rebaudioside A, Rebaudioside B, Rebaudioside C, 
Rebaudioside D, Rebaudioside E, Rebaudioside F, 
Stevioside, Dulcoside A and Steviolbioside, [3] however 
there are many more steviol related-molecules which have 
been reported elsewhere. [4] In Stevia varieties usually 
cultivated, Rebaudioside A and Stevioside are the 
glycosides found in greater quantities whereas other 
glycosides are found in lesser amounts. [1, 5]  
Since 2008 the Food and Drug Administration in the 
United States (FDA) granted the status of "Generally 
Recognized As Safe" (GRAS) to Rebaudioside A for use 
as a sweetener and in the same year, the JECFA and The 
Food Standards of Australia and New Zealand (FSANZ) 
established the acceptable daily intake (ADI) to steviol 
glycosides at 0-4 mg/kg bw/day (based on steviol 
equivalents). [6] The FDA does not allow the use of crude 
whole-leaf extracts of S. rebaudiana, and only isolated 
steviol glycosides with a purity of at least 95% are 
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permitted. [7] However, in the local market dried leaves 
of S. rebaudiana can be found to prepare homemade 
extracts or to sweeten hot beverages and even as capsules 
to be consumed as food supplements. 
Some studies have shown that S. rebaudiana extracts 
have an antihyperglycemic activity in diabetic rats, [8-10] 
and subsequent studies have attributed this to stevioside 
as it increases insulin production and lowers blood 
glucose in rats. [11-13] However, those studies performed 
with extracts of S. rebaudiana have not quantified total 
steviol glycosides including stevioside, and it is known 
that several factors contribute to the amount and type of 
glycosides in Stevia rebaudiana, such as plant variety, 
weather conditions, soil and extraction method. [14,15] 
In a previous work, we evaluate the effect of acute 
administration of 10 mg/kg of extract of S. rebaudiana 
Morita II grown in Mexico, without finding any 
hypoglycemic effect; [16] however the dose used could 
be very conservative and do not represent regular 
consumption as it was administered intraperitoneally. 
Since regular consumption of S. rebaudiana could be as 
crude whole-leaf extracts or food supplement, which 
glycoside content is unknown, the aim of this study was 
to evaluate the euglycemic effect of oral administration of 
extracts of S. rebaudiana varieties cultivated in Mexico in 
normoglycemic and induced-diabetic Wistar rats and 
quantify their glycosides content. 
 
II. MATERIALS AND METHODS 
1. Materials and reagents 
1.1 Reagents 
Standards of Rebaudioside B (ASB-00018227), 
Rebaudioside C (ASB-00018228), Rebaudioside D (ASB-
00018229), Steviolbioside (ASB-00019349) and 
Dulcoside A (ASB-00004949) were purchased from 
Chromadex (Irvine, CA, USA), and Stevioside (Sigma 
S3572) and Rebaudioside A (Sigma 01432) were 
purchased from Sigma-Aldrich (USA). The standards 
were lyophilized under vacuum pressure of 133 x 10-3 bar 
at -40 ºC (Labconco, Kansas City, MO, USA), suspended 
in HPLC grade water, filtered with 0.45 um membrane 
and frozen at -20 °C until use. Acetonitrile and HPLC 
grade water were purchased from J.T. Baker 
(Phillipsburg, NJ, USA). Streptozotocin, Nicotinamide 
and Glibenclamide were purchased from Sigma-Aldrich 
(St. Louis, MO) and commercial Metformin was used 
(Glucophage ®). 
1.2. Experimental animals 
Wistar rats (200-250 g) were purchased from Regional 
Research Center "Dr. Hideyo Noguchi" at the 
Universidad Autónoma de Yucatán. The animals were 
kept under controlled temperature (24 °C) with light-dark 
cycle. Food and drinking water was administered ad 
libitum. All procedures were conducted in accordance 
with the Official Mexican Standard “Norma Oficial 
Mexicana NOM-062-ZOO-1999, Especificaciones 
técnicas para la producción, cuidado y uso de los 
animales de laboratorio”. [17] 
1.3. Plant material 
First cut leaves of two varieties of Stevia rebaudiana were 
collected. Morita II variety was grown in experimental 
field from INIFAP in Tizimín, Yucatán, México, whereas 
Criolla variety was grown in a farm field located in 
Quintana Roo, México. Leaves obtained were dried in the 
shade and powdered in Willey mill mesh of 1 mm and 
protected from light for later use. 
 
2. Procedures 
2.1. Aqueous extracts of S. rebaudiana Bertoni 
Five hundred milligrams of leaves of each S. rebaudiana 
variety was extracted three times with 5 mL of HPLC 
grade water each time in a boiling water bath (100 ºC) for 
30 min; extracts were cooled to room temperature and 
subsequently centrifuged for 10 minutes at 2,500 x g and 
10 °C. The supernatant was transferred to a 25 mL 
volumetric flask and filled to capacity after the last 
extraction. [18] Extracts were filtered through a 
membrane filter (0.45 m) to remove any solid residue 
before HPLC analysis or lyophilized (133 x 10-3 bar and -
40 ºC) for in vivo tests on rats.  
2.2. Diabetes Mellitus induction 
DM Induction was performed in Wistar rats after 12 hours 
of fasting. Intraperitoneal injection of 65 mg/kg of 
streptozotocin dissolved in citrate-phosphate buffer (0.1 
M, pH 4.5) was performed 15 minutes after 
administration of 120 mg/kg (i.p.) of nicotinamide. [19] 
Two weeks later, the blood glucose was measured from 
the tip of the tail and only animals with glucose 200 mg 
were included. [20] 
2.3. Evaluation of hypoglycemic effect in 
normoglycemic Wistar rats 
After 16 hours of fasting, lyophilized extracts of S. 
rebaudiana Criolla, Morita II (100 and 200 mg/kg), 
distilled water (2.5 mL) or glibenclamide (5 mg/kg) were 
administered to rats through an intragastric tube. 
Lyophilized extracts and glibenclamide were weighted at 
corresponding dose and suspended in 2.5 mL of distilled 
water immediately before being administered. Glucose 
was measured in the blood of the tip of the tail using a 
commercial glucometer Optimun Xceed (Abbott) at time 
0 and 1, 3, 5 and 7 hours. [21] Glucose value at 0 h was 
considered as basal and percentage of change in glucose 
at each time were later calculated. 
2.4. Evaluation of antihyperglycemic effect in induced-
diabetic Wistar rats 
The evaluation of the antihyperglycemic effect was made 
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only with the highest dose (200 mg/kg) of S. rebaudiana 
Criolla or Morita II. In induced-diabetic rats, procedure 
was repeated. After 16 hours of fasting, distilled water, 
glibenclamide and S. rebaudiana Criolla or Morita II 
were administered to rats through an intragastric tube and 
glucose measured at time 0 and up to 7 hours. [21] 
Glucose value at 0 h was considered as basal and 
percentage of change in glucose at each time were later 
calculated. 
2.5. Evaluation of antihyperglycemic effect in 
normoglycemic Wistar rats by a glucose load  
This evaluation was also performed with the highest dose 
(200 mg/kg) of S. rebaudiana Criolla or Morita II. In 
normoglycemic rats and after 16 hours of fasting, a load 
of glucose (2 g/kg) was administered through an 
intragastric tube 10 min before treatments. Treatments 
administration was set as 0 h and glucose was measured 
in the blood of the tip of the tail at time 0, 0.5, 1, 2, 3 and 
4h. [20] Glucose value at 0 h was considered as basal and 
percentage of change in glucose at each time were later 
calculated. 
2.6. Chromatographic conditions and quantification of 
steviol glycosides 
According to JECFA (2010), [3] liquid chromatography 
was performed using an Agilent 100 HPLC system with a 
UV-Vis detector set to a wavelength of 210 nm. 
Chromatographic method was carried out using a Luna 
C18(2) 100A (Phenomenex Co., Ltd., CA, USA) column 
(250 mm length, 4.6 mm internal diameter and 5 m 
particle size) with mobile phase of 32:68 (v/v) acetonitrile 
and buffer sodium phosphate 10 mmol/L (pH 2.6), and 
isocratic flow at 1 mL/min. The results were analyzed 
with the Clarity program version 2.7.3.498 (2000-2009). 
Standard solutions were prepared at concentration ranges 
of 100-500 g/mL for Rebaudioside A and Stevioside 
whereas the rest of glycosides at 25–150 μg/mL. Each 
concentration was injected a total of six times onto the 
HPLC equipment. Quantification of the steviol glycosides 
content was based on peak area, from linear regression 
curves of the standards. [22, 23] 
 
3. Statistical analysis 
The analysis was performed using the statistical package 
Statgraphics, by t-test or ANOVA Student. Differences 
were considered significant with a p-value <0.05. 
 
 
III. RESULTS AND DISCUSSION 
Single oral administration of both varieties of S. 
rebaudiana at any dose tested, had not hypoglycemic 
effect in normoglycemic rats (Fig. 1). In this assay, as can 
be seen in Figure 1, there is a slight decrease in the 
percentage of change in glucose at 5 hours in all the 
experimental groups. As this phenomenon also occurred 
in the control group it could be attributed to the period of 
fasting reached at that time (21 hours approximate) or 
also be the result of mild stress caused by repeated 
measurement of glucose and handling of animals. [24] As 
expected, the group treated with glibenclamide had a 
marked hypoglycemia from the first hour, reaching the 
peak (approximately -60%) at 3 hours and remaining 
constant up to 7 hours.  
As in normoglycemic rats, administration of S. 
rebaudiana varieties in induced-diabetic rats had no 
antihyperglycemic effect (Fig. 2). No variety of S. 
rebaudiana at the dose tested had any effect on glucose. 
As expected, glibenclamide exerted his glucose lowering 
effect but it is north worthy that the effect of 
glibenclamide was more powerful in normoglycemic rats 
compared to induced-diabetic rats, as glucose lowering 
was greater (-60 vs. -40%) and in a shorter time (1 vs. 5 
hours). 
Finally, as seen in figure 3, any of the varieties at the 
highest dose had an antihyperglycemic effect in 
normoglycemic rats subjected to glucose load. The only 
effect was in the group treated with glibenclamide, with a 
similar response (-60%) at 3 h as observed in single 
administration (Fig. 1). 
The steviol glycoside content of S. rebaudiana B. 
varieties grown in the Yucatán is presented in Table 1. 
It is noteworthy that the quantification of glycosides was 
obtained from a previously validated HPLC method, 
which chromatographic data and validation parameters 
can be consulted elsewhere. [22, 23] In this regard, all 
steviol glycosides are at lower concentration than 
previously reported, [22, 23] possibly attributed to a 
different batch. Comparing the varieties Morita II and 
Criolla, there are no differences in the content of minor 
glycosides, except for Rebaudioside B and Rebaudioside 
D; however, the most important difference are the content 
of Stevioside and Rebaudioside A. Morita II variety had 
higher content of total glycosides as compared to the 
Criolla variety (16.74 vs. 9.65 g/100 g) with a higher 
content of Rebaudioside A (4.5 times more). It is known 
that Stevioside is 250-300 times sweeter than sugar but 
with a slightly bitter aftertaste, while Rebaudioside A has 
more sweetener capacity (350-450 times more than sugar) 
without bitter taste. [1] The Rebaudioside A to Stevioside 
ratio is a commonly measure used of sweetness quality, 
[4] and as expected Morita II had a better profile with a 
ratio of 5.9, unlike Criolla which ratio was 0.52. Taking 
into account the total content of glycosides, particularly 
Rebaudioside A and its sweetness quality, Morita II 
variety cultivated in Mexico is suitable for the food 
industry. 
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The quantification of steviol glycosides in S. rebaudiana 
extracts through a validated chromatographic method, 
allowed to set the steviol glycoside content administered 
in 100 and 200 mg/kg of lyophilized extracts. Steviol 
glycoside administration expressed in mg/kg is detailed in 
table 2, considering the highest dose used (200 mg/kg). 
There are studies that have evaluated the hypoglycemic 
effect of S. rebaudiana extracts, with varying results. In 
Wistar rats with alloxan-induced diabetes, chronic 
administration had hypoglycemic effect, [8, 9] but the 
administration in normoglycemic Wistar rats had no 
antihyperglycemic effect during a glucose tolerance test. 
[25]. Aqueous extract of S. rebaudiana administered (400 
mg/kg) during 28 days to Sprague-Dawley rats with 
streptozotocin-induced diabetes had an antihyperglycemic 
effect through PPAR- mechanism. [10] 
However, studies by Misra et al (2011) [9] as well as the 
Kujur et al (2010) [8] used extracts with another polarity 
and not aqueous. On the other hand, Assaei et al (2016) 
[10] although they used and aqueous extract and 
elucidated a mechanism, used a higher dose of extract 
without quantification of steviol glycosides and therefore, 
no comparisons can be made. 
Stevioside is the molecule that has been attributed the 
euglycemic effects of Stevia as has been shown to inhibit 
gluconeogenesis and increase production of insulin in 
vivo [11-13] and in vitro. [26] 
It has been reported that acute administration of a dose of 
200 mg/kg of stevioside in normoglycemic Wistar rats, 
increases the plasma insulin concentration but has no 
effect on glucose tolerance during the test. [11] In this 
context, the administration of 100 mg/kg of S. rebaudiana 
is equivalent to 4.58 mg/kg of stevioside in Morita 
variety, while in Criolla variety it is equivalent to 15.21 
mg/kg of stevioside (Table 2) which in both cases are 
much less than that the dose used by Jeppesen et al 
(2002). [11] 
Administration of stevioside in diabetic rats at doses of 20 
mg/kg for 14 days, [27] 25 mg/kg for 6 weeks, [12] or 30 
mg/kg for 3 weeks [13] has shown antihyperglycemic 
effect during oral or intravenous glucose tolerance tests. 
In these studies the dose of stevioside are higher than that 
used in this study, administration was for several days and 
with a different diabetes model. 
Nevertheless, high amounts of stevioside do not represent 
the usual consumption of this steviol glycoside as a 
sweetener since its sweetening power has been calculated 
as 300 times sweeter than sugar. [1] That is, the sweetness 
of even the small amount of 1 mg/kg of stevioside would 
be equivalent to using 18 grams of sugar for a 60 kg 
person. 
The administration of Criolla variety extracts, despite its 
relative high content of stevioside had no effect on blood 
glucose levels in normoglycemic and induced-diabetic 
rats, suggesting that the presence of this compound in 
varieties grown in southeast Mexico is not sufficient to 
achieve an in vivo effect on glucose. However it cannot be 
ruled out that chronic consumption could have a different 
effect.  
It is known that S. rebaudiana leaves also contain protein, 
fats and carbohydrates, diterpenes, flavonoids, tannins, 
among other phytochemicals, [28] not quantified in this 
project and that might have some effect on the regulation 
of glycaemia. Further studies are needed to fully 
characterize the extracts in addition to glycosides content. 
The administration S. rebaudiana extracts had no effect 
on glucose in normoglycemic or diabetic-induced Wistar 
rats. The relevance of the results are that the diabetes 
model used in this study was more close to clinical 
reality, since it is considered Type 2 diabetes unlike 
alloxan, [29] whose model is considered type 1 diabetes; 
type 2 diabetes model is more relevant since this type 
affects 90-95% of people with diabetes. [30] Furthermore, 
the intragastric administration of S. rebaudiana resembles 
oral consumption through food, infusions (as aqueous 
extract) or even food supplements. This might suggest 
that the consumption of S. rebaudiana extract varieties 
cultivated in southeast Mexico is safe to be consumed by 
healthy or diabetic individuals, however further studies 
are needed.  
 
IV. FIGURES AND TABLES 
 
Fig.1: Evaluation of hypoglycemic effect of S. rebaudiana 
extracts in normoglycemic rats. Each point represents the 
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average of variation in the percentage of glucose after 
administration of extracts from Criolla (a) or Morita II 
(b) variety of 5 animals ± SEM. Statistical significance by 
One-way ANOVA and post-hoc Tukey HSD vs controls 
denoted by ** p <0.01. 
 
Fig.2: Evaluation of antihyperglycemic effect of S. 
rebaudiana extracts in induced-diabetic rats with induced 
diabetes mellitus. Each point represents the average of 
variation in the percentage of glucose after 
administration of extracts from Criolla or Morita II 
variety of 5 animals ± SEM. Statistical significance by 
One-way ANOVA and post-hoc Tukey HSD vs controls 
denoted by ** p <0.01. 
Fig.3: Evaluation of antihyperglycemic effect of S. 
rebaudiana extracts in normoglycemic rats with glucose 
load. Each point represents the average of variation in 
the percentage of glucose after administration of glucose 
load and extracts from Criolla or Morita II variety of 5 
animals ± SEM. Statistical significance by One-way 
ANOVA and post-hoc Tukey HSD vs controls denoted by 
** p <0.01. 
 
Table.1: Contents of glycosides in g/100 g of dried leaves 
of S. rebaudiana Morita II and Criolla 
Steviol 
glycoside 
Morita II Criolla 
Mean  D.E. Mean  D.E. 
Dulcoside A 0.11  0.000 0.13  0.03 
Steviol 
glycoside 
Morita II Criolla 
Mean  D.E. Mean  D.E. 
Rebaudioside B 0.46  0.01 ** 0.16  0.03 ** 
Rebaudioside C 0.81  0.07 0.56  0.17 
Rebaudioside D 0.67  0.04 * 0.49  0.06 * 
Steviolbioside 0.32  0.15  0.38  0.11  
Rebaudioside A 12.29  0.27 ** 2.71  0.08 ** 
Stevioside 2.08  0.11 ** 5.22  0.23 ** 
Values are expressed as mean ± standard deviation. The 
significant differences found in the same row are denoted 
denote by  *p <0.05, **p <0.01 (Student's t-test). 
 
Table.2: Steviol glycosides dose (mg/kg) administered in 
200 mg/kg of lyophilized extract of Stevia rebaudiana B. 
Steviol glycosides Dose (mg/kg) according to Stevia 
rebaudiana variety 
Morita II Criolla 
Dulcoside A 0.48 0.76 
Rebaudioside B 2.03 0.93 
Rebaudioside C 3.57 3.26 
Rebaudioside D 2.95 2.86 
Steviolbioside 1.41 2.21 
Rebaudioside A 54.14 15.79 
Stevioside 9.16 30.42 
TOTAL 73.74 56.23 
Values are expressed as mean of steviol glycoside 
content. 
 
V. CONCLUSION 
The highest dose orally administered (200 mg/kg) of 
lyophilized Stevia rebaudiana extract contains 30.42 and 
9.16 mg/kg of stevioside and about 56 or 74 mg/kg of 
total steviol glycosides in Criolla and Morita II varieties, 
respectively, with no acute euglycemic effect in 
normoglycemic or induced-diabetic rats. These results 
suggest that it is unlikely that the use of S. rebaudiana 
leaves as sweetener or food supplement could decrease 
glucose in normoglycemic or diabetic people since the 
acceptable daily intake of glycosides is 4 mg/kg. 
 
VI. ACKNOWLEDGEMENTS 
The authors acknowledge the funding provided by the 
Fondos Fiscales-INIFAP and CONACyT for the 
scholarship provided to Aranda-González for her 
postgraduate studies. 
 
REFERENCES 
[1] Goyal SK, Samsher, Goyal RK. Stevia (Stevia 
rebaudiana) a bio-sweetener: a review. Int J Food 
Sci Nutr. 2010;61(1):1-10.  
 International Journal of Environment, Agriculture and Biotechnology (IJEAB)                               Vol-2, Issue-1, Jan-Feb- 2017 
 http://dx.doi.org/10.22161/ijeab/2.1.44                                                                                                                     ISSN: 2456-1878 
www.ijeab.com                                                                                                                                                                           Page | 359  
[2] Chaturvedula VS, Upreti M, Prakash I. Diterpene 
glycosides from Stevia rebaudiana. Molecules. 
2011;16(5):3552-62.  
[3] JECFA. Steviol glycosides. In: Compendium of 
Food Additive Specifications. FAO JECFA 
Monographs; Roma, 2010, pp. 17-21. 
[4] Ceunen S, Geuns JM. Steviol glycosides: chemical 
diversity, metabolism, and function. J Nat Prod. 
2013;76(6):1201-28.  
[5] Jackson AU, Tata A, Wu C, Perry RH, Haas G, 
West L, et al. Direct analysis of Stevia leaves for 
diterpene glycosides by desorption electrospray 
ionization mass spectrometry. Analyst. 
2009;134(5):867-74.  
[6] FDA. Rebaudioside A: GRAS assessment. In: 
Center of Food Safety and Applied Nutrition. FDA: 
USA, 2008, pp. 1-40. 
[7] Abdel-Rahman A, Anyangwe N, Carlacci L, Casper 
S, Danam RP, Enongene E, et al. The safety and 
regulation of natural products used as foods and 
food ingredients. Toxicol Sci. 2011;123(2):333-48.  
[8] Kujur RS, Singh V, Ram M, Yadava HN, Singh KK, 
Kumari S, et al. Antidiabetic activity and 
phytochemical screening of crude extract of Stevia 
rebaudiana in alloxan-induced diabetic rats. 
Pharmacognosy Res. 2010;2(4):258-63.  
[9] Misra H, Soni M, Silawat N, Mehta D, Mehta BK, 
Jain DC. Antidiabetic activity of medium-polar 
extract from the leaves of Stevia rebaudiana Bert. 
(Bertoni) on alloxan-induced diabetic rats. J Pharm 
Bioallied Sci. 2011;3(2):242-8.  
[10] Assaei R, Mokarram P, Dastghaib S, Darbandi S, 
Darbandi M, Zal F, et al. Hypoglycemic Effect of 
Aquatic Extract of Stevia in Pancreas of Diabetic 
Rats: PPARgamma-dependent Regulation or 
Antioxidant Potential. Avicenna J Med Biotechnol. 
2016;8(2):65-74.  
[11] Jeppesen PB, Gregersen S, Alstrup KK, Hermansen 
K. Stevioside induces antihyperglycaemic, 
insulinotropic and glucagonostatic effects in vivo: 
studies in the diabetic Goto-Kakizaki (GK) rats. 
Phytomedicine. 2002;9(1):9-14.  
[12] Jeppesen PB, Gregersen S, Rolfsen SE, Jepsen M, 
Colombo M, Agger A, et al. Antihyperglycemic and 
blood pressure-reducing effects of stevioside in the 
diabetic Goto-Kakizaki rat. Metabolism. 
2003;52(3):372-8.  
[13] Jeppesen PB, Dyrskog SE, Agger A, Gregersen S, 
Colombo M, Xiao J, et al. Can stevioside in 
combination with a soy-based dietary supplement be 
a new useful treatment of type 2 diabetes? An in 
vivo study in the diabetic goto-kakizaki rat. Rev 
Diabet Stud. 2006;3(4):189-99.  
[14] Jarma-Orozco A, Araméndiz-Tatis H, Cleves-
Leguízamo. Phenotypic stability and plant densities 
of stevia (Stevia rebaudiana Bert.) genotypes in the 
Caribbean Region of Colombia. Acta Agronómica. 
2011;60(2). 
[15] Kolb N, Herrera JL, Ferreyra DJ, Uliana RF. 
Analysis of sweet diterpene glycosides from Stevia 
rebaudiana: improved HPLC method. J Agric Food 
Chem. 2001;49(10):4538-41.  
[16] Aranda-Gonzalez I, Barbosa-Martin E, Toraya-
Aviles R, Segura-Campos M, Moguel-Ordonez Y, 
Betancur-Ancona D. Safety assessment of Stevia 
rebaudiana Bertoni grown in southeastern Mexico 
as food sweetener. Nutr Hosp. 2014;30(3):594-601.  
[17] Diario Oficial de la Federación. NOM-062-ZOO-
1999. Especificaciones técnicas para el Cuidado y 
Uso de los Animales de Laboratorio. Norma Oficial 
Mexicana, México, 2001. 
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